NDC 49288-0430

Quack Grass

Quack Grass

Quack Grass is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Elymus Repens Pollen.

Product ID49288-0430_0247493a-8221-44f5-afa6-071bde3bfac2
NDC49288-0430
Product TypeHuman Prescription Drug
Proprietary NameQuack Grass
Generic NameQuack Grass
Dosage FormInjection, Solution
Route of AdministrationINTRADERMAL; SUBCUTANEOUS
Marketing Start Date1974-03-23
Marketing CategoryBLA / BLA
Application NumberBLA102223
Labeler NameAntigen Laboratories, Inc.
Substance NameELYMUS REPENS POLLEN
Active Ingredient Strength0 g/mL
Pharm ClassesNon-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 49288-0430-5

50 mL in 1 VIAL, MULTI-DOSE (49288-0430-5)
Marketing Start Date1974-03-23
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 49288-0430-3 [49288043003]

Quack Grass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0430-4 [49288043004]

Quack Grass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0430-5 [49288043005]

Quack Grass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0430-2 [49288043002]

Quack Grass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

NDC 49288-0430-1 [49288043001]

Quack Grass INJECTION, SOLUTION
Marketing CategoryBLA
Application NumberBLA102223
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1974-03-23
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
ELYMUS REPENS POLLEN.05 g/mL

OpenFDA Data

SPL SET ID:c7d383a6-94b8-4101-8a4c-fa7747a21468
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 889573
  • 852676
  • 852517
  • 852346
  • 852228
  • 852220
  • 1232641
  • 1006509
  • 1115952
  • 889671
  • 898407
  • 1098458
  • 852117
  • 852018
  • 852332
  • 852662
  • 852139
  • 852135
  • 1014777
  • 1014738
  • 1014734
  • 852700
  • 898132
  • Pharmacological Class

    • Non-Standardized Pollen Allergenic Extract [EPC]
    • Increased Histamine Release [PE]
    • Cell-mediated Immunity [PE]
    • Increased IgG Production [PE]
    • Pollen [CS]
    • Allergens [CS]

    NDC Crossover Matching brand name "Quack Grass" or generic name "Quack Grass"

    NDCBrand NameGeneric Name
    36987-2355Quack GrassQuack Grass
    36987-2356Quack GrassQuack Grass
    36987-2357Quack GrassQuack Grass
    36987-2358Quack GrassQuack Grass
    36987-2359Quack GrassQuack Grass
    36987-2360Quack GrassQuack Grass
    36987-2361Quack GrassQuack Grass
    36987-2362Quack GrassQuack Grass
    49288-0430Quack GrassQuack Grass
    0268-1418ELYMUS REPENS POLLENQuack Grass
    0268-1419ELYMUS REPENS POLLENQuack Grass
    0268-1420ELYMUS REPENS POLLENQuack Grass
    0268-6657ELYMUS REPENS POLLENQuack Grass

    Trademark Results [Quack Grass]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    QUACK GRASS
    QUACK GRASS
    76540462 3038953 Dead/Cancelled
    Allen, Kevin
    2003-08-27

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.